| Erynn Crawford, LCSW | |
|
13770 Sw 24th St, Beaverton, OR 97008-5055 | |
| (630) 936-9583 | |
| Not Available |
| Full Name | Erynn Crawford |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 13770 Sw 24th St, Beaverton, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356113096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | L11286 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erynn Crawford, LCSW 13770 Sw 24th St, Beaverton, OR 97008-5055 Ph: (630) 936-9583 | Erynn Crawford, LCSW 13770 Sw 24th St, Beaverton, OR 97008-5055 Ph: (630) 936-9583 |
News Archive
Biotechnology Industry Organization Industry Analysis and BioMedTracker announced results of a study today that shows the overall success rate for drugs moving through clinical trials to FDA approval from late 2003 to the end of 2010 is near one in 10. Previous reports, taken from earlier years, showed the rate of drug approvals is one in five to one in six.
In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at the National Institutes of Health, say those outcomes would have been unimaginable about 10 years ago, prior to the drugs' availability.
LifePoint Hospitals, Inc. today announced results for the third quarter and nine months ended September 30, 2009.
Novo Nordisk has announced that Norditropin (somatropin[rDNA origin] injection) received U.S. Food and Drug Administration (FDA) approval for the treatment of short stature in children with Noonan syndrome.
Stroke researchers have found that the presence of frontal lesions predicts better functional improvement in individuals with spatial neglect who received prism adaptation therapy. "Integrity of medial temporal structures may predict better improvement of spatial neglect with prism adaptation treatment" was published in September in the Neuroimaging and Rehabilitation Special Issue of Brain Imaging & Behavior.
› Verified 8 days ago
Alan Hershman, L.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 14255 Sw Brigadoon Ct Ste 80, Beaverton, OR 97005 Phone: 503-641-1475 | |
Carla E Fadriquela, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2980 Sw 123rd Ave, Beaverton, OR 97005 Phone: 808-281-4616 | |
Tiffanie B Galupi, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1925 Ne Stucki Ave, Beaverton, OR 97006 Phone: 503-906-5000 | |
Stephanie Anne Cox, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6900 Sw 105th Ave Ste B, Beaverton, OR 97008 Phone: 541-638-0830 | |
Ms. Aja Riley Bennett, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 15270 Sw Mallard Dr Ste 101, Beaverton, OR 97007 Phone: 214-454-1447 | |
Tucker Hardy, MSW, CSWA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10700 Sw Beaverton Hillsdale Hwy Ste 350, Beaverton, OR 97005 Phone: 971-279-2067 Fax: 971-302-6956 | |
Jessica Edit Villasenor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4537 Sw 96th Ave, Beaverton, OR 97005 Phone: 503-376-9520 |